Explore Products
Tumor Cell Lines

BT-474

  • BSL

    1

  • 230
The BT-474 line was isolated by E. Lasfargues and W.G. Coutinho from a solid, invasive ductal carcinoma of the breast.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Product Code

Bt-474; BT474

Species

Human

Cat.No

ABC-TC0085

Product Category Tumor Cell Lines
Size/Quantity

1 vial

Cell Type

Epithelial

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Breast

Disease

Ductal Cancer

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Human Breast Cancer Cell Lines

Description

BT-474BT-474 is a human breast tumor cell line that was originally isolated from the breast tissue of a 60-year-old white female patient with invasive ductal carcinoma. BT-474 exhibits epithelial-like morphology and adherent/patchy culture properties. BT-474 is shown as aneuploid expression with the chromosome mode numbers of 55. These cells express high levels of progesterone receptors (PR), estrogen receptor positive (ER), and human epidermal growth factor receptor 2 (HER2). BT-474 is tumorigenic in nude mice. These characteristics make it a powerful model for studying hormone-responsive breast cancer.

View Product Image

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

  • The BT-474 cell line finds valuable applications in preclinical breast cancer research, offering a direct link to real patients with matching genetic profiles. This model proves indispensable in drug discovery endeavors, facilitating the development of innovative targeted treatments for breast cancer. Its utilization spans from investigating small molecules and antibodies to refining cell-based therapies, enhancing the prospects of advancing effective interventions for breast cancer patients.

Inquiring BT-474

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button